These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24239684)

  • 21. [Treatment of prostate cancer using cryoablation: a prospective study].
    Govorov AV; Vasil'ev AO; Ivanov VIu; Kovylina MV; Prilepskaia EA; Pushkar' DIu
    Urologiia; 2014; (6):69-72, 74. PubMed ID: 25799731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting biopsy-proven prostate cancer recurrence following cryosurgery.
    Caso JR; Tsivian M; Mouraviev V; Polascik TJ
    Urol Oncol; 2012; 30(4):391-5. PubMed ID: 20826095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation.
    Cerqueira MA; Ferrari KL; de Mattos AC; Monti CR; Reis LO
    World J Urol; 2020 Mar; 38(3):673-680. PubMed ID: 31263944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryosurgery for prostate cancer.
    Fahmy WE; Bissada NK
    Arch Androl; 2003; 49(5):397-407. PubMed ID: 12893518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer.
    Benzon B; Glavaris SA; Simons BW; Hughes RM; Ghabili K; Mullane P; Miller R; Nugent K; Shinder B; Tosoian J; Fuchs EJ; Tran PT; Hurley PJ; Vuica-Ross M; Schaeffer EM; Drake CG; Ross AE
    Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):126-136. PubMed ID: 29556048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of cryotherapy in localized prostatic carcinoma].
    Sommer F; Derakhshani P; Zumbé J; Engelmann U
    Urologe A; 2001 May; 40(3):185-90. PubMed ID: 11405126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proactive rectal warming during total-gland prostate cryoablation.
    Chen CH; Pu YS
    Cryobiology; 2014 Jun; 68(3):431-5. PubMed ID: 24662028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose Escalation of Vitamin D
    Santucci KL; Baust JM; Snyder KK; Van Buskirk RG; Baust JG
    Cancer Control; 2018; 25(1):1073274818757418. PubMed ID: 29480024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-Gland Prostate Cancer Cryoablation with Magnetic Resonance Imaging Guidance: One-Year Follow-Up.
    Kinsman KA; White ML; Mynderse LA; Kawashima A; Rampton K; Gorny KR; Atwell TD; Felmlee JP; Callstrom MR; Woodrum DA
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):344-349. PubMed ID: 29043385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems.
    Klossner DP; Robilotto AT; Clarke DM; VanBuskirk RG; Baust JM; Gage AA; Baust JG
    Cryobiology; 2007 Dec; 55(3):189-99. PubMed ID: 17888898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphology of hypoxia following cryoablation in a prostate cancer murine model: its relationship to necrosis, apoptosis and, microvessel density.
    Kimura M; Rabbani Z; Mouraviev V; Tsivian M; Vujaskovic Z; Satoh T; Baba S; Baust JM; Baust JG; Polascik TJ
    Cryobiology; 2010 Aug; 61(1):148-54. PubMed ID: 20599882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cryoablation of localized prostate cancer. Current state].
    Witzsch UK; Becht E
    Urologe A; 2009 Jul; 48(7):719-28. PubMed ID: 19547948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological findings in the prostate two years following cryosurgical ablation.
    Donnelly BJ; Saliken JC; Ali-Ridha N; Rewcastle JC; White LJ
    Can J Urol; 2001 Apr; 8(2):1237-9. PubMed ID: 11375788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cryoablation: a scientific rationale for future modifications.
    Rukstalis DB; Goldknopf JL; Crowley EM; Garcia FU
    Urology; 2002 Aug; 60(2 Suppl 1):19-25. PubMed ID: 12206844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
    Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
    Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of primary and salvage cryoablation for prostate cancer.
    Chin JL; Lim D; Abdelhady M
    Cancer Control; 2007 Jul; 14(3):231-7. PubMed ID: 17615528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression.
    Klossner DP; Baust JM; VanBuskirk RG; Gage AA; Baust JG
    BJU Int; 2008 May; 101(10):1310-6. PubMed ID: 18261151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathology of the frozen prostate. The microscopic bases of prostatic carcinoma cryoablation.
    Falconieri G; Lugnani F; Zanconati F; Signoretto D; Di Bonito L
    Pathol Res Pract; 1996 Jun; 192(6):579-87. PubMed ID: 8857646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Issues critical to the successful application of cryosurgical ablation of the prostate.
    Baust JG; Gage AA; Klossner D; Clarke D; Miller R; Cohen J; Katz A; Polascik T; Clarke H; Baust JM
    Technol Cancer Res Treat; 2007 Apr; 6(2):97-109. PubMed ID: 17375972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes.
    Larson TR; Rrobertson DW; Corica A; Bostwick DG
    Urology; 2000 Apr; 55(4):547-52. PubMed ID: 10736499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.